Ask AI
ProCE Banner Activity

MASTer Class in Systemic Mastocytosis: Expert Answers to Your Questions

Clinical Thought

Learn how to counsel patients with systemic mastocytosis (SM) about the chronic nature of their disease, what symptoms and red flags warrant a referral to allergy and immunology, and how SM is differentiated among other mast cell activation disorders in adult and pediatric patients.

Released: February 19, 2026

Continue Activity View Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

ProCE Banner

Supporters

Supported by an educational grant from Blueprint Medicines, a Sanofi company.

Blueprint Medicines, a Sanofi company

Target Audience

This activity is intended for US-based physicians, including residents and fellows; physician associates; and nurse practitioners practicing in allergy/immunology and dermatology who care for patients with systemic mastocytosis. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the pathogenesis, spectrum of clinical presentation, and differential diagnosis of SM

Financial Disclosures

Primary Author

Benjamin Ungar, MD: consultant/advisor/speaker: AbbVie, Botanix, Bristol Myers Squibb, Ebla Holdco, Galderma, Johnson & Johnson, Leo Pharma, Lilly, Nektar, Pfizer, Sanofi, Veradermics, VRG Therapeutics.